- Home
- APVO vs APDN Comparison
APVO vs APDN Comparison
Compare APVO & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- APDN
- Stock Information
- Founded
- APVO 2016
- APDN 1983
- Country
- APVO United States
- APDN United States
- Employees
- APVO N/A
- APDN N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- APVO Health Care
- APDN Consumer Discretionary
- Exchange
- APVO Nasdaq
- APDN Nasdaq
- Market Cap
- APVO 4.1M
- APDN 4.2M
- IPO Year
- APVO N/A
- APDN N/A
- Fundamental
- Price
- APVO $4.95
- APDN $5.37
- Analyst Decision
- APVO Strong Buy
- APDN Strong Buy
- Analyst Count
- APVO 1
- APDN 1
- Target Price
- APVO $5,920.00
- APDN $1,125.00
- AVG Volume (30 Days)
- APVO 393.8K
- APDN 129.8K
- Earning Date
- APVO 05-14-2025
- APDN 05-15-2025
- Dividend Yield
- APVO N/A
- APDN N/A
- EPS Growth
- APVO N/A
- APDN N/A
- EPS
- APVO N/A
- APDN N/A
- Revenue
- APVO N/A
- APDN $3,790,616.00
- Revenue This Year
- APVO N/A
- APDN $57.08
- Revenue Next Year
- APVO N/A
- APDN $40.00
- P/E Ratio
- APVO N/A
- APDN N/A
- Revenue Growth
- APVO N/A
- APDN N/A
- 52 Week Low
- APVO $4.30
- APDN $4.37
- 52 Week High
- APVO $658.60
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- APVO 28.32
- APDN 22.45
- Support Level
- APVO $4.30
- APDN $4.96
- Resistance Level
- APVO $5.18
- APDN $6.50
- Average True Range (ATR)
- APVO 1.22
- APDN 1.06
- MACD
- APVO 0.72
- APDN 0.39
- Stochastic Oscillator
- APVO 6.47
- APDN 17.44
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.